Rapport Therapeutics stock tumbles on $350M capital raise
· uk.investing.com · popularity 12/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at uk.investing.com →
Summary
Investing.com -- Rapport Therapeutics Inc (NASDAQ:RAPP) shares fell 20% in premarket trading Wednesday following the pricing of $350 million in …
Found in: Stocks. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 30.